LeMaitre Vascular Inc (LMAT)

Return on total capital

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 36,712 34,304 31,272 27,368 27,490 28,123 31,030 36,432 36,506 37,584 38,572 32,455 28,665 24,344 20,191 21,446 21,679 23,684 22,407 27,860
Long-term debt US$ in thousands 0 0 19,448 28,485 35,532 36,229 36,990 0
Total stockholders’ equity US$ in thousands 297,900 288,637 283,827 274,165 268,201 261,247 258,033 257,787 254,151 249,048 185,833 177,525 172,572 160,983 152,629 148,835 148,141 142,316 137,537 133,088
Return on total capital 12.32% 11.88% 11.02% 9.98% 10.25% 10.76% 12.03% 14.13% 14.36% 15.09% 18.79% 15.75% 13.77% 12.34% 10.65% 14.41% 14.63% 16.64% 16.29% 20.93%

December 31, 2023 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $36,712K ÷ ($—K + $297,900K)
= 12.32%

The return on total capital for Lemaitre Vascular Inc has shown some fluctuations over the quarters. In Q4 2023, the return on total capital was 12.49%, indicating that the company generated a return of 12.49% on its total capital employed during that period. This was a slight improvement compared to the previous quarter, where the return was 11.76%. However, it is lower than the levels seen in the earlier quarters of 2022, where the return on total capital ranged from 11.97% to 14.12%.

Overall, the return on total capital indicates the efficiency with which the company is utilizing its capital to generate profits. While the recent return of 12.49% is relatively healthy, it is important for Lemaitre Vascular Inc to maintain or improve this metric to ensure sustainable profitability and effective capital allocation in the long run.


Peer comparison

Dec 31, 2023